Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.

Autor: Au HJ, Karapetis CS, O'Callaghan CJ, Tu D, Moore MJ, Zalcberg JR, Kennecke H, Shapiro JD, Koski S, Pavlakis N, Charpentier D, Wyld D, Jefford M, Knight GJ, Magoski NM, Brundage MD, Jonker DJ, Au, Heather-Jane, Karapetis, Christos S, O'Callaghan, Chris J

Publikováno v: Journal of Clinical Oncology; 4/10/2009, Vol. 27 Issue 11, p1822-1828, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study.

Autor: Dawson LA; University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: laura.dawson@uhn.ca., Ringash J; University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Fairchild A; Cross Cancer Institute, Edmonton, AB, Canada., Stos P; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada., Dennis K; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada., Mahmud A; Cancer Centre Southeastern Ontario, Kingston General Hospital, Kingston, ON, Canada., Stuckless TL; Dr H Bliss Murphy Cancer Centre, Memorial University, St John's, NL, Canada., Vincent F; Centre Intégré Universitaire de Santé et Services Sociaux, Mauricie-Centre-du Québec, Trois-Rivières, QC, Canada., Roberge D; Centre Hospitalier Universitaire de Montréal, Montreal, QC, Canada., Follwell M; Royal Victoria Regional Health Care Centre, Barrie, ON, Canada., Wong RKW; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Jonker DJ; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada., Knox JJ; University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Zimmermann C; University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Wong P; University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Barry AS; Cancer Research at University College Cork, Cork University Hospital, Cork, Ireland., Gaudet M; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada., Wong RKS; University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Purdie TG; University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Tu D; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada., O'Callaghan CJ; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Oct; Vol. 25 (10), pp. 1337-1346. Date of Electronic Publication: 2024 Sep 05.

Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.

Autor: Loree JM; BC Cancer, University of British Columbia, Vancouver, Canada., Titmuss E; BC Cancer, University of British Columbia, Vancouver, Canada., Topham JT; BC Cancer, University of British Columbia, Vancouver, Canada., Kennecke HF; Oregon Health & Science University, Portland, Oregon., Feilotter H; Canadian Clinical Trials Group, Kingston, Canada., Virk S; Canadian Clinical Trials Group, Kingston, Canada., Lee YS; AstraZeneca, Gaithersburg, Maryland., Banks K; Guardant Health, Redwood, California., Quinn K; Guardant Health, Redwood, California., Karsan A; BC Cancer, University of British Columbia, Vancouver, Canada., Renouf DJ; BC Cancer, University of British Columbia, Vancouver, Canada., Jonker DJ; The Ottawa Hospital, University of Ottawa, Ottawa, Canada., Tu D; Canadian Clinical Trials Group, Kingston, Canada., O'Callaghan CJ; Canadian Clinical Trials Group, Kingston, Canada., Chen EX; Princess Margaret Cancer Centre, Toronto, Canada.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 01; Vol. 30 (15), pp. 3189-3199.